CalciMedica, Inc. (CALC) has a consensus analyst rating of Buy, based on 3 analysts covering the stock. Of those, 2 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for CALC is $266.00, representing a +41,783.2% upside from the current price of $0.6351. Price targets range from a low of $14.00 to a high of $392.00.
